PHARMACOKINETIC DATA AS BASIS FOR DRUG CLEARANCE BY EXTRACORPOREAL METHODS

被引：0
|
作者：
KELLER, E
机构：
来源：
NIEREN-UND HOCHDRUCKKRANKHEITEN | 1990年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：439 / 442
页数：4
相关论文
共 50 条
  • [31] EXPERIMENTAL INDEXES OF POLYMORPHIC DRUG OXIDATION - PHARMACOKINETIC BASIS AND DISCRIMINATORY POWER
    JACKSON, PR
    TUCKER, GE
    LENNARD, MS
    WOODS, HF
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 216 - 216
  • [32] ESTABLISHMENT OF MAXIMUM RECOMMENDED DOSES ON THE BASIS OF TOXICOLOGICAL AND PHARMACOKINETIC DATA
    NIESEL, HC
    KAISER, H
    ANAESTHESIST, 1991, 40 (08): : A79 - A82
  • [33] Revisiting the Rule of Five on the Basis of Pharmacokinetic Data from Rat
    Ridder, Lars
    Wang, Hongwu
    de Vlieg, Jacob
    Wagener, Markus
    CHEMMEDCHEM, 2011, 6 (11) : 1967 - 1970
  • [34] PHARMACOKINETIC CHARACTERIZATION OF EXTRACORPOREAL THERAPY
    PEDERSEN, H
    HORVATH, C
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (04): : 437 - 454
  • [35] DETECTION OF DRUG-DRUG INTERACTIONS FROM POPULATION PHARMACOKINETIC DATA
    GRASELA, TH
    ANTAL, EJ
    SMITH, RB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (02) : 196 - 196
  • [36] PHARMACOKINETIC (PK) BASIS OF STATIN DRUG-DRUG INTERACTION (DDI) INFORMATION IN FDA LABELS
    Mease, J.
    Ramamoorthy, A.
    Yang, X.
    Madabushi, R.
    Fletcher, E. Pfuma
    Zineh, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S13 - S13
  • [37] In vitro and in vivo methods to assess pharmacokinetic drug- drug interactions in drug discovery and development
    Lu, Chuang
    Di, Li
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2020, 41 (1-2) : 3 - 31
  • [38] DRUG BIOAVAILABILITY AND PHARMACOKINETIC ANALYSIS FROM PHARMACOLOGICAL DATA
    SMOLEN, VF
    WEIGAND, WA
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1973, 1 (04): : 329 - 336
  • [39] CRITICISM OF PHARMACOKINETIC CLEARANCE CONCEPTS
    KELLER, F
    SCHOLLE, J
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1983, 21 (11) : 563 - 568
  • [40] Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
    Germovsek, Eva
    Barker, Charlotte I. S.
    Sharland, Mike
    Standing, Joseph F.
    CLINICAL PHARMACOKINETICS, 2019, 58 (01) : 39 - 52
12345